Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases

Peptide‐based supramolecular therapeutics (PST) refer to those theranostic nanomedicines based on peptide or peptide derivatives self‐assembly that are constructed in vitro or in vivo. Benefiting from the inherent advantages of peptides, such as good biocompatibility, high bioactivity, and flexible...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced functional materials 2024-06, Vol.34 (25), p.n/a
Hauptverfasser: Wang, Zhongyan, Luo, Hongjing, Wang, Heping, Xiao, Meng, Jia, Haixue, Ren, Chunhua, Liu, Jianfeng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 25
container_start_page
container_title Advanced functional materials
container_volume 34
creator Wang, Zhongyan
Luo, Hongjing
Wang, Heping
Xiao, Meng
Jia, Haixue
Ren, Chunhua
Liu, Jianfeng
description Peptide‐based supramolecular therapeutics (PST) refer to those theranostic nanomedicines based on peptide or peptide derivatives self‐assembly that are constructed in vitro or in vivo. Benefiting from the inherent advantages of peptides, such as good biocompatibility, high bioactivity, and flexible tunability, the reported PST have shown excellent application prospects in combating many major diseases including cancer, cardiovascular disease, infectious disease, autoimmune disease, metabolic disease, and so on. Through thoughtful design, the PST can be fabricated in various forms, including self‐assembled precursor molecules, functional nano‐assemblies, and macroscopic large‐scale hydrogels. The involved peptides in the PST can play different roles, such as serving drug carriers for effective delivery, acting as scaffold materials for cell culture, and functioning as bioactive sequences for treating diseases. In this review, a comprehensive overview of traditional strategies is provided to build PST and emphasize their therapeutic applications for fighting major diseases that pose a threat to human life and health. Moreover, the main challenges of PST in systems design, therapeutic application, and clinical translation are also briefly discussed. It is hoped that this review can arouse much more attention to be paid for PST and promote its practical application in the biomedical field. In this review, a comprehensive overview of traditional strategies is provided to build PST and emphasize their therapeutic applications for fighting major diseases that pose a threat to human life and health including cancer, cardiovascular and cerebrovascular diseases, infectious diseases, autoimmune diseases, etc. The main challenges of PST in systems design, therapeutic application, and clinical translation are also briefly discussed. It is hoped that this review can arouse much more attention to be paid for PST and promote its practical application in the biomedical field.
doi_str_mv 10.1002/adfm.202314492
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3069539574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3069539574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3172-44008bdef6e7d665631e44a63d297a0840d8c7aec3704fbe690c4f6272a4b3e83</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRsFavngOeU2c_upsca2ur0KJgBW_LdnfSpqRN3E2Q3vwJ_kZ_iSmVevQ078DzzMBLyDWFHgVgt8Zlmx4DxqkQKTshHSqpjDmw5PSY6ds5uQhhDUCV4qJDJs9Y1bnD78-vOxPQRS9N5c2mLNA2hfHRfIXeVNjUuQ1RVvponC9Xdb5dRjOzbtdRHrD1wiU5y0wR8Op3dsnr-H4-fIinT5PH4WAaW04Vi4UASBYOM4nKSdmXnKIQRnLHUmUgEeASqwxarkBkC5QpWJFJppgRC44J75Kbw93Kl-8Nhlqvy8Zv25eag0z7PO0r0VK9A2V9GYLHTFc-3xi_0xT0viy9L0sfy2qF9CB85AXu_qH1YDSe_bk_BGhucQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3069539574</pqid></control><display><type>article</type><title>Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wang, Zhongyan ; Luo, Hongjing ; Wang, Heping ; Xiao, Meng ; Jia, Haixue ; Ren, Chunhua ; Liu, Jianfeng</creator><creatorcontrib>Wang, Zhongyan ; Luo, Hongjing ; Wang, Heping ; Xiao, Meng ; Jia, Haixue ; Ren, Chunhua ; Liu, Jianfeng</creatorcontrib><description>Peptide‐based supramolecular therapeutics (PST) refer to those theranostic nanomedicines based on peptide or peptide derivatives self‐assembly that are constructed in vitro or in vivo. Benefiting from the inherent advantages of peptides, such as good biocompatibility, high bioactivity, and flexible tunability, the reported PST have shown excellent application prospects in combating many major diseases including cancer, cardiovascular disease, infectious disease, autoimmune disease, metabolic disease, and so on. Through thoughtful design, the PST can be fabricated in various forms, including self‐assembled precursor molecules, functional nano‐assemblies, and macroscopic large‐scale hydrogels. The involved peptides in the PST can play different roles, such as serving drug carriers for effective delivery, acting as scaffold materials for cell culture, and functioning as bioactive sequences for treating diseases. In this review, a comprehensive overview of traditional strategies is provided to build PST and emphasize their therapeutic applications for fighting major diseases that pose a threat to human life and health. Moreover, the main challenges of PST in systems design, therapeutic application, and clinical translation are also briefly discussed. It is hoped that this review can arouse much more attention to be paid for PST and promote its practical application in the biomedical field. In this review, a comprehensive overview of traditional strategies is provided to build PST and emphasize their therapeutic applications for fighting major diseases that pose a threat to human life and health including cancer, cardiovascular and cerebrovascular diseases, infectious diseases, autoimmune diseases, etc. The main challenges of PST in systems design, therapeutic application, and clinical translation are also briefly discussed. It is hoped that this review can arouse much more attention to be paid for PST and promote its practical application in the biomedical field.</description><identifier>ISSN: 1616-301X</identifier><identifier>EISSN: 1616-3028</identifier><identifier>DOI: 10.1002/adfm.202314492</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc</publisher><subject>Autoimmune diseases ; Biocompatibility ; Biological activity ; Biomedical materials ; Disease ; Drug carriers ; Infectious diseases ; major disease ; Metabolic disorders ; nanomedicine ; peptide ; Peptides ; Self-assembly ; supramolecular therapeutics ; Systems design</subject><ispartof>Advanced functional materials, 2024-06, Vol.34 (25), p.n/a</ispartof><rights>2024 Wiley‐VCH GmbH</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3172-44008bdef6e7d665631e44a63d297a0840d8c7aec3704fbe690c4f6272a4b3e83</citedby><cites>FETCH-LOGICAL-c3172-44008bdef6e7d665631e44a63d297a0840d8c7aec3704fbe690c4f6272a4b3e83</cites><orcidid>0000-0003-2967-719X ; 0000-0003-0541-5072</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadfm.202314492$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadfm.202314492$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Wang, Zhongyan</creatorcontrib><creatorcontrib>Luo, Hongjing</creatorcontrib><creatorcontrib>Wang, Heping</creatorcontrib><creatorcontrib>Xiao, Meng</creatorcontrib><creatorcontrib>Jia, Haixue</creatorcontrib><creatorcontrib>Ren, Chunhua</creatorcontrib><creatorcontrib>Liu, Jianfeng</creatorcontrib><title>Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases</title><title>Advanced functional materials</title><description>Peptide‐based supramolecular therapeutics (PST) refer to those theranostic nanomedicines based on peptide or peptide derivatives self‐assembly that are constructed in vitro or in vivo. Benefiting from the inherent advantages of peptides, such as good biocompatibility, high bioactivity, and flexible tunability, the reported PST have shown excellent application prospects in combating many major diseases including cancer, cardiovascular disease, infectious disease, autoimmune disease, metabolic disease, and so on. Through thoughtful design, the PST can be fabricated in various forms, including self‐assembled precursor molecules, functional nano‐assemblies, and macroscopic large‐scale hydrogels. The involved peptides in the PST can play different roles, such as serving drug carriers for effective delivery, acting as scaffold materials for cell culture, and functioning as bioactive sequences for treating diseases. In this review, a comprehensive overview of traditional strategies is provided to build PST and emphasize their therapeutic applications for fighting major diseases that pose a threat to human life and health. Moreover, the main challenges of PST in systems design, therapeutic application, and clinical translation are also briefly discussed. It is hoped that this review can arouse much more attention to be paid for PST and promote its practical application in the biomedical field. In this review, a comprehensive overview of traditional strategies is provided to build PST and emphasize their therapeutic applications for fighting major diseases that pose a threat to human life and health including cancer, cardiovascular and cerebrovascular diseases, infectious diseases, autoimmune diseases, etc. The main challenges of PST in systems design, therapeutic application, and clinical translation are also briefly discussed. It is hoped that this review can arouse much more attention to be paid for PST and promote its practical application in the biomedical field.</description><subject>Autoimmune diseases</subject><subject>Biocompatibility</subject><subject>Biological activity</subject><subject>Biomedical materials</subject><subject>Disease</subject><subject>Drug carriers</subject><subject>Infectious diseases</subject><subject>major disease</subject><subject>Metabolic disorders</subject><subject>nanomedicine</subject><subject>peptide</subject><subject>Peptides</subject><subject>Self-assembly</subject><subject>supramolecular therapeutics</subject><subject>Systems design</subject><issn>1616-301X</issn><issn>1616-3028</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkE1Lw0AQhhdRsFavngOeU2c_upsca2ur0KJgBW_LdnfSpqRN3E2Q3vwJ_kZ_iSmVevQ078DzzMBLyDWFHgVgt8Zlmx4DxqkQKTshHSqpjDmw5PSY6ds5uQhhDUCV4qJDJs9Y1bnD78-vOxPQRS9N5c2mLNA2hfHRfIXeVNjUuQ1RVvponC9Xdb5dRjOzbtdRHrD1wiU5y0wR8Op3dsnr-H4-fIinT5PH4WAaW04Vi4UASBYOM4nKSdmXnKIQRnLHUmUgEeASqwxarkBkC5QpWJFJppgRC44J75Kbw93Kl-8Nhlqvy8Zv25eag0z7PO0r0VK9A2V9GYLHTFc-3xi_0xT0viy9L0sfy2qF9CB85AXu_qH1YDSe_bk_BGhucQ</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Wang, Zhongyan</creator><creator>Luo, Hongjing</creator><creator>Wang, Heping</creator><creator>Xiao, Meng</creator><creator>Jia, Haixue</creator><creator>Ren, Chunhua</creator><creator>Liu, Jianfeng</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SP</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><orcidid>https://orcid.org/0000-0003-2967-719X</orcidid><orcidid>https://orcid.org/0000-0003-0541-5072</orcidid></search><sort><creationdate>20240601</creationdate><title>Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases</title><author>Wang, Zhongyan ; Luo, Hongjing ; Wang, Heping ; Xiao, Meng ; Jia, Haixue ; Ren, Chunhua ; Liu, Jianfeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3172-44008bdef6e7d665631e44a63d297a0840d8c7aec3704fbe690c4f6272a4b3e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Autoimmune diseases</topic><topic>Biocompatibility</topic><topic>Biological activity</topic><topic>Biomedical materials</topic><topic>Disease</topic><topic>Drug carriers</topic><topic>Infectious diseases</topic><topic>major disease</topic><topic>Metabolic disorders</topic><topic>nanomedicine</topic><topic>peptide</topic><topic>Peptides</topic><topic>Self-assembly</topic><topic>supramolecular therapeutics</topic><topic>Systems design</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Zhongyan</creatorcontrib><creatorcontrib>Luo, Hongjing</creatorcontrib><creatorcontrib>Wang, Heping</creatorcontrib><creatorcontrib>Xiao, Meng</creatorcontrib><creatorcontrib>Jia, Haixue</creatorcontrib><creatorcontrib>Ren, Chunhua</creatorcontrib><creatorcontrib>Liu, Jianfeng</creatorcontrib><collection>CrossRef</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Advanced functional materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Zhongyan</au><au>Luo, Hongjing</au><au>Wang, Heping</au><au>Xiao, Meng</au><au>Jia, Haixue</au><au>Ren, Chunhua</au><au>Liu, Jianfeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases</atitle><jtitle>Advanced functional materials</jtitle><date>2024-06-01</date><risdate>2024</risdate><volume>34</volume><issue>25</issue><epage>n/a</epage><issn>1616-301X</issn><eissn>1616-3028</eissn><abstract>Peptide‐based supramolecular therapeutics (PST) refer to those theranostic nanomedicines based on peptide or peptide derivatives self‐assembly that are constructed in vitro or in vivo. Benefiting from the inherent advantages of peptides, such as good biocompatibility, high bioactivity, and flexible tunability, the reported PST have shown excellent application prospects in combating many major diseases including cancer, cardiovascular disease, infectious disease, autoimmune disease, metabolic disease, and so on. Through thoughtful design, the PST can be fabricated in various forms, including self‐assembled precursor molecules, functional nano‐assemblies, and macroscopic large‐scale hydrogels. The involved peptides in the PST can play different roles, such as serving drug carriers for effective delivery, acting as scaffold materials for cell culture, and functioning as bioactive sequences for treating diseases. In this review, a comprehensive overview of traditional strategies is provided to build PST and emphasize their therapeutic applications for fighting major diseases that pose a threat to human life and health. Moreover, the main challenges of PST in systems design, therapeutic application, and clinical translation are also briefly discussed. It is hoped that this review can arouse much more attention to be paid for PST and promote its practical application in the biomedical field. In this review, a comprehensive overview of traditional strategies is provided to build PST and emphasize their therapeutic applications for fighting major diseases that pose a threat to human life and health including cancer, cardiovascular and cerebrovascular diseases, infectious diseases, autoimmune diseases, etc. The main challenges of PST in systems design, therapeutic application, and clinical translation are also briefly discussed. It is hoped that this review can arouse much more attention to be paid for PST and promote its practical application in the biomedical field.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/adfm.202314492</doi><tpages>28</tpages><orcidid>https://orcid.org/0000-0003-2967-719X</orcidid><orcidid>https://orcid.org/0000-0003-0541-5072</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1616-301X
ispartof Advanced functional materials, 2024-06, Vol.34 (25), p.n/a
issn 1616-301X
1616-3028
language eng
recordid cdi_proquest_journals_3069539574
source Wiley Online Library Journals Frontfile Complete
subjects Autoimmune diseases
Biocompatibility
Biological activity
Biomedical materials
Disease
Drug carriers
Infectious diseases
major disease
Metabolic disorders
nanomedicine
peptide
Peptides
Self-assembly
supramolecular therapeutics
Systems design
title Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T02%3A07%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peptide%E2%80%90Based%20Supramolecular%20Therapeutics%20for%20Fighting%20Major%20Diseases&rft.jtitle=Advanced%20functional%20materials&rft.au=Wang,%20Zhongyan&rft.date=2024-06-01&rft.volume=34&rft.issue=25&rft.epage=n/a&rft.issn=1616-301X&rft.eissn=1616-3028&rft_id=info:doi/10.1002/adfm.202314492&rft_dat=%3Cproquest_cross%3E3069539574%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3069539574&rft_id=info:pmid/&rfr_iscdi=true